Skip to content

The Correlation Between Testosterone and Cortisol Level and Inflammatory Markers Levels in Type 2 Diabetic Men.

The Correlation Between Testosterone and Cortisol Level and Inflammatory Markers Levels in Type 2 Diabetic Men.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02529306
Acronym
BZMC
Enrollment
40
Registered
2015-08-20
Start date
2015-09-01
Completion date
2019-09-30
Last updated
2018-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetic

Keywords

men

Brief summary

Many type 2 diabetic men have low serum testosterone levels. Our aim in this trial is to check if there is a correlation between serum or hair testosteron levels and serum or hair cortisol levels in type 2 diabetic men. We'll also examine whether there is a correlation between serum and hair testosterone levels and cortisol levels and serum inflammatory markers. If such correlation will be found- then it is possible that excess cortisol or an abnormal inflammatory status- may cause the low testosterone levels that seen in type 2 diabetic men.

Detailed description

Eligible participants are type 2 diabetic men who visit our clinic, as part of their routine medical surveillance, and other 10 healthy volunteers (men) as a control group. All the participants will sign an informed consent form. The study will include 30 type 2 diabetic men, (40-55 years old) and 10 healthily volunteers (same age group). In addition to routine blood test of blood count, kidney function and liver enzymes will be taken blood samples of total testosterone serum levels, total cortisol serum levels and serum inflammation markers levels, and also a sample of head-hair for cortisol and testosterone levels (1 cm of occipital hair weighing 50 mg). Optional: from patients who will agree to visit the clinic after 8 hours-fast will be also taken one additional blood sample of fasting glucose, insulin and C-peptide levels, in order to estimate their insulin resistance status, and it's possible correlation to the other measures. From the 10 healthy volunteers In addition will be taken blood and hair samples of the above parameters, as a control.

Interventions

None listed

Sponsors

Bnai Zion Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
40 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* men age 40-55 * type 2 diabetic

Exclusion criteria

* HIV * septic disease

Design outcomes

Primary

MeasureTime frameDescription
Testosterone level24 monthssingle blood and hair sample will be drawn to measure Testosterone levels (nmol/L)
Cortisol level24 monthssingle blood and hair sample will be drawn to measure cortisol levels (mcg/dl)
C-reactive protein levels24 monthssingle blood sample will be drawn to measure c-reactive protein levels (mcg/dl)
Anti Tumor Necrosis Factor alpha24 monthssingle blood sample will be drawn to measure Anti Tumor Necrosis Factor alpha levels (pg/ml)

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026